RespireRx - a podcast by OTC Markets Group

RespireRx (OTCQB: RSPI) is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of psychiatric and neurological disorders. President and CEO Tim Jones joins us to discuss the company’s competitive advantage in the biotechnology space.

 

View Podcast Transcript for RespireRx

Further episodes of OTCQB Podcast

Further podcasts by OTC Markets Group

Website of OTC Markets Group